A significant issue in the public understanding of science is the way in which citizens use digital media to influence policy making on cutting-edge research and emerging technologies. This study examines the public comments on the Food and Drug Administration's proposed guidelines for ATryn, the first drug manufactured from nonbacterial recombinant DNA, that is, human-animal gene splicing.
Description
Color poster with text, charts, and graphs.
Sponsor(s)
University of Wisconsin--Eau Claire Office of Research and Sponsored Programs